Premium
Methadone N ‐demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4
Author(s) -
Foster David J. R.,
Somogyi Andrew A.,
Bochner Felix
Publication year - 1999
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1046/j.1365-2125.1999.00921.x
Subject(s) - cyp3a4 , microsome , chemistry , demethylation , stereoselectivity , cyp2b6 , cyp3a , pharmacology , pharmacokinetics , metabolite , methadone , cytochrome p450 , metabolism , enzyme , biochemistry , biology , gene , gene expression , dna methylation , catalysis
Aims To investigate the kinetics of CYP‐mediated N ‐demethylation of methadone in human liver microsomes, and examine the role of stereoselectivity and CYP isoforms involved. Methods The kinetics of 2‐ethylidene‐1,5‐dimethyl‐3,3‐diphenylpyrrolidine (EDDP) formation via N‐demethylation of rac ‐, (R)‐ and (S)‐methadone in human liver microsomes prepared from six liver samples were determined by h.p.l.c., and inhibition of metabolic function was studied using isoform‐specific chemical inhibitors and monoclonal antibodies. Microsomes containing expressed CYP3A4, CYP2D6 and CYP2C19 were also used to examine the formation of EDDP. Results The V max , K m , and CL int values for the formation of EDDP from rac‐, (R)‐ and (S)‐methadone were in the ranges of 20–77 nmol mg −1 protein h −1 , 125–252 μm, and 91–494 ml h −1 g −1 protein. K m and CL int values for (R)‐ and (S)‐methadone were not statistically significantly different (P >0.05), while V max values for (S)‐methadone were 15% (P=0.045) lower than for (R)‐methadone. Expressed CYP3A4 and CYP2C19 showed similar reaction rates for both (R)‐ and (S)‐methadone, while CYP2D6 did not catalyse this reaction. Selective chemical inhibitors of CYP3A (troleandomycin, ketoconazole) and monoclonal human CYP3A4 antibodies significantly inhibited (P<0.05) the formation of EDDP in a concentration dependent manner by up to 80%. Sulphaphenazole (CYP2C9) also significantly inhibited (P<0.05) EDDP formation (range 14–25%). There were no statistically significant differences in the inhibition observed between the three substrates. Selective inhibitors of CYP1A2 (furafylline), CYP2A6 (coumarin), CYP2C19 ((S)‐mephenytoin), CYP2D6 (quinidine) and CYP2E1 (diethyldithiocarbamic acid sodium salt and monoclonal human CYP2E1 antibodies) had no significant (P >0.05) effect. Conclusions The N‐demethylation of methadone in human liver microsomes is not markedly stereoselective, and is mediated mainly by CYP3A4 with the possible involvement of CYP2C9 and CYP2C19. Thus, the large interindividual variation reported for methadone pharmacokinetics may be due to variability in the expression of these CYP isoforms, and the reported stereoselectivity in the systemic clearance of methadone in vivo is not due to stereoselectivity in N ‐demethylation.